Skip to main content
Cesar Rodriguez Valdes, MD, Hematology, New York, NY

CesarRodriguez ValdesMD

Hematology New York, NY

Hematologic Oncology

Assistant Professor, Myeloma and plasma cell disorders program Director, Associate Director Maya Angelou Center for Health Equity, Wake Forest School of Medicine, Comprehensive Cancer Center

Dr. Rodriguez Valdes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rodriguez Valdes' full profile

Already have an account?

  • Office

    10 E 102nd St
    New York, NY 10029
    Phone+1 212-241-6756

Summary

  • I am a myeloma specialist in charge of clinical and transactional research for the Myeloma Program at Wake Forest University. I do clinical care including stem cell transplants and cell therapy. My translational research focus is on myeloma organoids to understand chemoresistance.

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Texas Tech University HSC El Paso
    Texas Tech University HSC El PasoResidency, Internal Medicine, 2006 - 2009
  • Monterrey Inst Tech
    Monterrey Inst TechClass of 2005
  • ITESM
    ITESM MD

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 2021 - 2026
  • NC State Medical License
    NC State Medical License 2015 - 2021
  • KY State Medical License
    KY State Medical License 2009 - 2016
  • SC State Medical License
    SC State Medical License 2008 - 2013
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top 40 under 40 Business Insider, 2015
  • National Patient's Choice Award 2014
  • Leukemia and Lymphoma Society Man of the Year LLS, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • KLF9-dependent ROS regulate melanoma progression in stage-specific Manner  
    M Nikiforov, A Bagati, S Moparthy, E Fink, A Bianchi-Smiraglia, D Yun, M Kolesnikova, O Udartseva, D Wolff, M Roll, B Lipchik, N Kozlova, P Jowdy, A Berman, N Box, ES ..., Oncogene, 1/21/2019
  • Paraproteinemia and serum protein electrophoresis interpretation  
    SK Raj, B Guha, C Rodriguez, B Krishnaswamy, Ann Allrgy Asthma Immunol, 1/1/2019
  • Guidance from ASMBT Practice Guidelines Committee for establishing a long term follow-up clinic for hematopoietic cell transplant survivors  
    SK Hashmi, SJ Lee, BN Savani, L Burns, JR Wingard, MA Perales, J Palmer, E Chow, E Meyer, D Marks, M Mohty, Y Inamoto, C Rodriguez, JD Rizzo, PA Carpenter, BBMT, 1/30/2018
  • Join now to see all

Abstracts/Posters

  • Model of patient-specific multiple myeloma 3D printed organodis for predicting chemotherapy response: feasibility Study.
    J Aleman, A Maycock, S George, C Porada, G Almeida-Porada, C Rodriguez, A Skardal, NCTERMS, 1/23/2019
  • Assessment of treatment-related effects on cognition in multiple myeloma patients undergoing autologous stem cell transplant.
    *M Tam, E Dressler, K Duckworth, C Rodriguez, Women�s Health Research Day, 1/17/2019
  • Tacrolimus levels and correlation to age and weight calculation.
    Seegars MB, Isom S, Kennedy L, Anders B, Rodriguez C, ASBMT Oral and Poster Session II, Salt Lake City, 2/24/2018
  • Join now to see all

Lectures

  • Emerging Small Molecules in Multiple Myeloma 
    Atrium Health, Charlotte, NC - 1/11/2019
  • Insights into Managing Myeloma 
    Cary, NC - 1/7/2019
  • MNI Great Lakes Bone Health ECHO, Paraprotein Screening in Osteoporosis Patients 
    Michigan - 1/27/2018
  • Join now to see all

Other

  • (Featured article) Featured article on the research I am doing regarding 3D myeloma cultures. 
    Valdes CR, MD Anderson: The Multiple Myeloma Daily
    1/23/2019
  • Report on immunotherapy for myeloma treatment using first-in-human BiTE clinical trials at Wake Forest. 
    Valdes CR, WXII News
    1/22/2018
  • (Featured documentary) Participated on a documentary focused on myeloma awareness and the milestones in treatment thanks to ongoing research. 
    Valdes CR, Cures Magazine
    1/9/2018
  • Join now to see all

Press Mentions

  • International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific Assembly
    International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific AssemblyAugust 15th, 2024

Grant Support

  • Young InvestigatorCTSIPresent
  • Translational Research in MyelomaMyeloma Crowd Research InitiativePresent

Committees

  • member, CTN MRD and immune profiling 2016 - Present
  • member, CTN myeloma committee 2015 - Present
  • member, ASBMT Practice Guidelines 2015 - Present

Research History

  • Multiple Myeloma and Plasma Cell Disorders Lead2015 - Present

Professional Memberships

Other Languages

  • French, Italian, Spanish